Simplex Trading’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-222
| Closed | -$377K | – | 10542 |
|
|
2020
Q4 | $377K | Buy |
+222
| New | +$2.78K | ﹤0.01% | 3798 |
|
|
2020
Q1 | – | Sell |
-36
| Closed | -$16K | – | 8588 |
|
|
2019
Q4 | $16K | Sell |
36
-32
| -47% | -$127 | ﹤0.01% | 6131 |
|
|
2019
Q3 | $26K | Buy |
68
+58
| +580% | +$318 | ﹤0.01% | 5628 |
|
|
2019
Q2 | $6K | Sell |
10
-30
| -75% | -$287 | ﹤0.01% | 6415 |
|
|
2019
Q1 | $53K | Buy |
40
+19
| +90% | +$217 | ﹤0.01% | 4970 |
|
|
2018
Q4 | $19K | Buy |
21
+16
| +320% | +$190 | ﹤0.01% | 5391 |
|
|
2018
Q3 | $6K | Sell |
5
-1
| -17% | -$15 | ﹤0.01% | 6724 |
|
|
2018
Q2 | $9K | Sell |
6
-20
| -77% | -$349 | ﹤0.01% | 6433 |
|
|
2018
Q1 | $27K | Buy |
26
+13
| +100% | +$254 | ﹤0.01% | 3074 |
|
|
2017
Q4 | $11K | Sell |
13
-79
| -86% | -$2.54K | ﹤0.01% | 3853 |
|
|
2017
Q3 | $2K | Buy |
+92
| New | +$2.89K | ﹤0.01% | 5252 |
|
|
2017
Q2 | – | Sell |
-25
| Closed | -$28K | – | 7103 |
|
|
2017
Q1 | $28K | Buy |
25
+23
| +1,150% | +$1.01K | ﹤0.01% | 2928 |
|
|
2016
Q4 | $1K | Buy |
+2
| New | +$105 | ﹤0.01% | 5613 |
|
|
2016
Q3 | – | Sell |
-38
| Closed | -$8K | – | 6747 |
|
|
2016
Q2 | $8K | Buy |
38
+17
| +81% | +$739 | ﹤0.01% | 3862 |
|
|
2016
Q1 | $2K | Sell |
21
-36
| -63% | -$1.24K | ﹤0.01% | 4872 |
|
|
2015
Q4 | $1K | Buy |
57
+7
| +14% | +$235 | ﹤0.01% | 5108 |
|
|
2015
Q3 | $32K | Buy |
+50
| New | +$1.07K | ﹤0.01% | 2348 |
|
Simplex Trading's FPRX Position: Q2 2021 in Review
Simplex Trading sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 13,118 shares.
Simplex Trading first reported a position in FPRX in Q3 2015 and held it in 16 quarters. The position peaked at $308K in Q2 2018. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Simplex Trading reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Simplex Trading sold 13,118 Five Prime Therapeutics, Inc. shares in Q2 2021.
- Simplex Trading first reported a position in Five Prime Therapeutics, Inc. in Q3 2015 and held it in 16 quarters.
- Simplex Trading's Five Prime Therapeutics, Inc. position peaked at $308K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.